India's approach to pharmaceutical patents is gathering increased attention in Washington, with recent high-level pressure on the Indian government to do more to protect intellectual property.
Originally published in the October 23, 2013 edition of The Daily Journal.
Click here to read the full text of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.